AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Total liabilities

annual total liabilities:

$28.87M-$55.15M(-65.64%)
December 31, 2024

Summary

  • As of today (September 18, 2025), AMLX annual total liabilities is $28.87 million, with the most recent change of -$55.15 million (-65.64%) on December 31, 2024.
  • During the last 3 years, AMLX annual total liabilities has risen by +$11.44 million (+65.62%).
  • AMLX annual total liabilities is now -65.64% below its all-time high of $84.02 million, reached on December 31, 2023.

Performance

AMLX Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

quarterly total liabilities:

$26.72M+$8.46M(+46.34%)
June 1, 2025

Summary

  • As of today (September 18, 2025), AMLX quarterly total liabilities is $26.72 million, with the most recent change of +$8.46 million (+46.34%) on June 1, 2025.
  • Over the past year, AMLX quarterly total liabilities has dropped by -$44.13 million (-62.29%).
  • AMLX quarterly total liabilities is now -71.27% below its all-time high of $93.02 million, reached on March 31, 2024.

Performance

AMLX quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

AMLX Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-65.6%-62.3%
3 y3 years+65.6%-17.7%
5 y5 years+38.1%+204.8%

AMLX Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-65.6%+65.6%-71.3%+46.3%
5 y5-year-65.6%+229.3%-71.3%+204.8%
alltimeall time-65.6%+229.3%-71.3%+204.8%

AMLX Total liabilities History

DateAnnualQuarterly
Jun 2025
-
$26.72M(+46.3%)
Mar 2025
-
$18.26M(-36.8%)
Dec 2024
$28.87M(-65.6%)
$28.87M(-47.0%)
Sep 2024
-
$54.51M(-23.1%)
Jun 2024
-
$70.85M(-23.8%)
Mar 2024
-
$93.02M(+10.7%)
Dec 2023
$84.02M
$84.02M(+74.4%)
Sep 2023
-
$48.18M(-28.3%)
DateAnnualQuarterly
Jun 2023
-
$67.22M(+21.5%)
Mar 2023
-
$55.31M(+8.8%)
Dec 2022
$50.85M(+191.7%)
$50.85M(+35.9%)
Sep 2022
-
$37.41M(+15.3%)
Jun 2022
-
$32.45M(-3.1%)
Mar 2022
-
$33.49M(+92.1%)
Dec 2021
$17.43M(+98.8%)
$17.43M(+98.8%)
Dec 2020
$8.77M(-58.1%)
$8.77M
Dec 2019
$20.90M
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual total liabilities?
  • What is the all time high annual total liabilities for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual total liabilities year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual total liabilities?

The current annual total liabilities of AMLX is $28.87M

What is the all time high annual total liabilities for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual total liabilities is $84.02M

What is Amylyx Pharmaceuticals, Inc. annual total liabilities year-on-year change?

Over the past year, AMLX annual total liabilities has changed by -$55.15M (-65.64%)

What is Amylyx Pharmaceuticals, Inc. quarterly total liabilities?

The current quarterly total liabilities of AMLX is $26.72M

What is the all time high quarterly total liabilities for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly total liabilities is $93.02M

What is Amylyx Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?

Over the past year, AMLX quarterly total liabilities has changed by -$44.13M (-62.29%)
On this page